
S. Korea to launch advisory committee for arms exports
South Korea is preparing to launch an advisory committee under the state arms procurement agency, consisting mostly of non-governmental experts, to boost its defense technology exports, sources close to the matter said Wednesday.
The Defense Acquisition Program Administration recently came up with the plan and is "preparing to launch the committee,' a DAPA official told The Korea Herald via phone. 'The review and nomination of candidates will kick off in September.'
The committee will consist of 15 members who are considered experts in arms exports. Each member will serve for two years and may be nominated for an additional two-year term.
The committee members will be tasked with drafting strategies for the country's arms exports by cooperating with various teams within DAPA currently handling outbound shipments to continents including Europe, Africa, the Middle East, North America and more.
The latest plan follows President Lee Jae Myung's campaign pledge to buoy the defense industry, making it one of the country's top four future sectors alongside semiconductor, secondary batteries and automobile. As part of his pledge, Lee said he plans to regularly preside over defense export promotion and strategy meetings, which usually involve Army officials from the Office of National Security. South Korea would become one of the world's top four arms exporters, Lee said.
South Korea's arms exports fell to $9.5 billion last year after hitting a record high of $17.3 billion in 2022 and sliding to $13.5 billion in 2023.
Separate government sources said last week that South Korea is likely to sign a deal worth some $6 billion to export additional K2 tanks to Poland later this month.
If materialized, it would be Seoul's biggest single arms export contract to date.
Under the deal set to be signed in late June, Poland would receive 180 K2 tanks, of which 117 units will be produced by South Korean defense contractor Hyundai Rotem Co. The rest will be manufactured locally by Warsaw's state-owned PGZ.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Korea Herald
an hour ago
- Korea Herald
Lee orders Defense Ministry to devise redevelopment plans for ex-US military bases
President Lee Jae Myung on Tuesday ordered the Defense Ministry to come up with redevelopment plans for multiple former military bases and land located near the inter-Korean border that has been returned by the US Forces Korea. Lee ordered the ministry to 'proactively review' the issue of how to use the land during Tuesday's Cabinet meeting, presidential spokesperson Kang Yu-jung said during an afternoon briefing In 2004, Seoul and Washington agreed to relocate all US forces to garrisons located south of the Han River and move the USFK and United Nations Command headquarters to Camp Humphreys in Pyeongtaek, approximately 70 kilometers south of Seoul. The relocations were completed in 2018 and in the process, several US military bases near the border, including Camp Red Cloud, in Uijeongbu, Gyeonggi Province were shut down. The Gyeonggi provincial government in recent years has been struggling to come up with redevelopment plans for the abandoned bases. Lee's latest order is aligned with his campaign pledge to 'designate the border region as a special economic zone for peace' and 'expand government support for the returned US military sites and nearby areas.' The demilitarized zone would be redeveloped as an ecotourism district to be used for exchange and cooperation with North Korea, he added.


Korea Herald
2 hours ago
- Korea Herald
Seoul shares rise for 2nd day on hopes for US tariff talks, Commercial Act revision
South Korean stocks rose for a second straight session Tuesday as investors welcomed signs of progress in trade talks over the United States' tariff scheme and were keen on a potential revision of a shareholders-friendly law. The local currency fell against the US dollar. The benchmark Korea Composite Stock Price Index added 17.95 points, or 0.58 percent, to close at 3,089.65. Trade volume was moderate at 563.22 million shares worth 14.99 trillion won ($11.05 billion), with winners beating losers 706 to 185. Institutional and foreign investors bought a net 474.96 billion won and 180.7 billion won worth of stocks, respectively, while individuals net sold 637.69 billion won. The index opened higher, tracking overnight gains on Wall Street, and climbed further to hit a yearly high before paring some of its earlier gains. Investor sentiment was buoyed by signs of progress in trade talks between the US and Canada, as well as other trading partners, and by the possibility that the Federal Reserve may resume interest rate cuts. These factors pushed the S&P 500 and the tech-heavy Nasdaq to all-time highs on Monday (US time). Investors also closely watched the potential revision of the Commercial Act, which calls for expanding corporate directors' fiduciary duty to shareholders to better protect the rights of minority shareholders. The ruling Democratic Party has been pushing for the amendment, while the main opposition People Power Party has shifted its stance and pledged to review it favorably. Top cap shares finished mixed. Market bellwether Samsung Electronics soared 1.59 percent to 60,750 won, while chip giant SK hynix sank 1.28 percent to 288,250 won on profit taking. Major battery maker LG Energy Solution added 0.76 percent to 299,250 won, and No. 1 steelmaker POSCO Holdings spiked 5.75 percent to 276,000 won. Nuclear power plant manufacturer Doosan Enerbility shed 1.02 percent to 67,700 won following sharp gains in the previous session. Bio shares gathered ground. Leading biotech firm Samsung Biologics advanced 0.71 percent to 999,000 won, and Celltrion went up 0.31 percent to 160,100 won. Top carmaker Hyundai Motor surged 1.47 percent to 206,500 won, and its sister Kia Motors jumped 1.75 percent to 98,600 won. Leading financial firm KB Financial gained 0.81 percent to 111,800 won, and defense giant Hanwha Aerospace increased 0.47 percent to 852,000 won. Top online portal operator Naver rose 0.57 percent to 264,000 won, while Kakao, the operator of the country's dominant mobile messenger, climbed 2.33 percent to 61,400 won. The local currency was quoted at 1,350 won against the greenback at 3:30 p.m., down 5.9 won from the previous session. Bond prices, which move inversely to yields, closed mixed. The yield on three-year Treasurys rose 0.2 basis point to 2.454 percent, and the return on the benchmark five-year government bonds declined 1.0 basis points to 2.581 percent. (Yonhap)


Korea Herald
3 hours ago
- Korea Herald
TotalEnergies signs agreement with Daehwa Pharmaceutical in South Korea for a rooftop solar project
SEOUL, South Korea, July 1, 2025 /PRNewswire/ -- TotalEnergies has signed a Solar Power Operating Lease Agreement with South Korean pharmaceutical company Daehwa Pharmaceutical Co., Ltd. to install a 1.8 megawatt-peak (MWp) solar photovoltaic (PV) system. The project will be implemented at Daehwa Pharmaceutical's state-of-the-art production site in Hoengseong-gun, Gangwon-do. The signing ceremony was held at Daehwa Pharmaceutical's Seoul office in the Seocho District, with key representatives from both companies in attendance. Under this 20-year agreement, TotalEnergies will fully invest in, install, operate, and maintain the solar PV system on-site at the premises of Daehwa Pharmaceutical's facilities. The system will comprise over 2,800 solar PV modules and is expected to generate approximately 2,300 megawatt-hours (MWh) of clean electricity annually, equivalent to around 20% of Daehwa Pharmaceutical's current total electricity consumption, avoiding about 1,000 tons of CO 2 emissions annually. Through this collaboration, the two companies aim to replace a portion of the factory's electricity usage with clean energy, contributing to carbon emissions reduction and promoting a sustainable energy transition in compliance with the RE100 initiative. The project is expected to begin commercial operations in the second half of 2025, following the completion of permitting and construction processes. Richard Pullen, Representative Director of TotalEnergies Renewables Projects South Korea, commented: "This agreement stands as a model case of active participation in industrial decarbonization in Korea. Based on our partnership with Daehwa Pharmaceutical, we aim to further expand our renewable energy projects across the country." Eun-Seok Kim, CEO of Daehwa Pharmaceutical, stated, "Through the adoption of this solar power system, Daehwa aims not only to reduce annual energy costs but also to take a meaningful step toward realizing environmentally friendly values by lowering carbon emissions. ESG management is no longer a choice but a necessity, and we will continue to fulfill our role as a responsible company for a sustainable future." About TotalEnergies Renewables Distributed Generation in Asia TotalEnergies Renewables Distributed Generation is a major international provider of fully integrated distributed solar energy solutions, including solar-powered rooftops, carport and ground-mounted solar power plants, with 1.5 GW of projects in construction and operation worldwide. In Asia, TotalEnergies Renewables Distributed Generation is one of the largest and fastest players in renewable energy distributed generation in the region for commercial and industrial customers, with over 200 MW of projects in operation across 10 countries. TotalEnergies and electricity TotalEnergies is building a competitive portfolio that combines renewables (solar, onshore wind, offshore wind) and flexible assets (CCGT, storage) to deliver clean firm power to its customers. As of the end of March 2025, TotalEnergies has 28 GW of installed gross renewable electricity generation capacity and aims to reach 35 GW by the end of 2025, and more than 100 TWh of net electricity production by 2030. About TotalEnergies TotalEnergies is a global integrated energy company that produces and markets energies: oil and biofuels, natural gas, biogas and low-carbon hydrogen, renewables and electricity. Our more than 100,000 employees are committed to providing as many people as possible with energy that is more reliable, more affordable and more sustainable. Active in about 120 countries, TotalEnergies places sustainability at the heart of its strategy, its projects and its operations. About Daehwa Pharmaceutical Co., Ltd., Daehwa Pharmaceutical Co., Ltd., established in 1984 and listed on KOSDAQ in 2003, is a mid-sized Korean pharmaceutical company. It was the first to be certified as an "Innovative Pharmaceutical Company" by the Ministry of Health and Welfare in 2012 and has maintained this status through five consecutive renewals, valid until 2027. The company focuses on formulation technologies such as TDDS, ODF, and improved drugs, as well as natural substance-based dementia treatments. It operates three GMP-certified plants, including a cGMP-level facility for oral anticancer drugs. Key products include oral anticancer medication (Liporaxel®), topical treatments, analgesics, and HA filler 'Amalian' from its German subsidiary. Daehwa also provides OEM manufacturing of medical patches and is committed to ESG practices with multiple ISO certifications. TotalEnergies Contact Daehwa Pharmaceutical Co., Ltd., Contact Media Relation: Jihoon Ko (jihoon@ TotalEnergies on social media Cautionary Note TotalEnergies The terms "TotalEnergies", "TotalEnergies company" or "Company" in this document are used to designate TotalEnergies SE and the consolidated entities that are directly or indirectly controlled by TotalEnergies SE. Likewise, the words "we", "us" and "our" may also be used to refer to these entities or to their employees. The entities in which TotalEnergies SE directly or indirectly owns a shareholding are separate legal entities. This document may contain forward-looking information and statements that are based on a number of economic data and assumptions made in a given economic, competitive and regulatory environment. They may prove to be inaccurate in the future and are subject to a number of risk factors. Neither TotalEnergies SE nor any of its subsidiaries assumes any obligation to update publicly any forward-looking information or statement, objectives or trends contained in this document whether as a result of new information, future events or otherwise. Information concerning risk factors, that may affect TotalEnergies' financial results or activities is provided in the most recent Registration Document, the French-language version of which is filed by TotalEnergies SE with the French securities regulator Autorité des Marchés Financiers (AMF), and in the Form 20-F filed with the United States Securities and Exchange Commission (SEC).